| 000 | 01211 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250514000048.0 | ||
| 264 | 0 | _c20021106 | |
| 008 | 200211s 0 0 eng d | ||
| 022 | _a1465-6566 | ||
| 024 | 7 |
_a10.1517/14656566.2.4.537 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aArranz, M J | |
| 245 | 0 | 0 |
_aApplications of pharmacogenetics in psychiatry: personalisation of treatment. _h[electronic resource] |
| 260 |
_bExpert opinion on pharmacotherapy _cApr 2001 |
||
| 300 |
_a537-42 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAryl Hydrocarbon Hydroxylases _xgenetics |
| 650 | 0 | 4 | _aCytochrome P-450 CYP2C9 |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP2D6 _xgenetics |
| 650 | 0 | 4 | _aGenetic Variation |
| 650 | 0 | 4 | _aGenome, Human |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMental Disorders _xdrug therapy |
| 650 | 0 | 4 | _aPharmacogenetics |
| 650 | 0 | 4 |
_aReceptors, Neurotransmitter _xgenetics |
| 700 | 1 | _aMunro, J | |
| 700 | 1 | _aOsborne, S | |
| 700 | 1 | _aCollier, D | |
| 700 | 1 | _aKerwin, R W | |
| 773 | 0 |
_tExpert opinion on pharmacotherapy _gvol. 2 _gno. 4 _gp. 537-42 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/14656566.2.4.537 _zAvailable from publisher's website |
| 999 |
_c11269711 _d11269711 |
||